MGTX MeiraGTx Holdings Market Valuation

Public company logo of meiragtx.com (MGTX)

MeiraGTx Holdings plc (MGTX) is a leading biopharmaceutical developer investing in the creation of riboswitches to combat neurodegeneration and vision loss. The price trend on GURU.Markets is 0.85, reflecting the company's market position. The business relies on the trust of global pharma behemoths and expert recognition. The brand has earned leader status thanks to unique gene expression control methods for the therapy of severe pathologies.

MGTX (meiragtx.com) Market Capitalization history from 07/04/2022 to 11/17/2026

MeiraGTx Holdings plc - analytical breakdowns and key metrics (MGTX)

- current price and projected stock value:
Fundamental company analysis:MGTX (MeiraGTx Corp)
Original product of MeiraGTx Corp

The scaling of MeiraGTx Holdings plc (MGTX) within the rare disease gene therapy segment drives the dynamics of the company's valuation chart, reflecting the aggregate market demand for its assets. This indicator sums all outstanding shares at the current price, allowing investors to compare actual market capitalization against untapped market potential and strategic partnerships, which is critical for determining long-term business sustainability.

Competitors of MeiraGTx Holdings plc (MGTX)

Market Capitalization TEM (Tempus AI, Inc)|Market Capitalization Qiagen Group|IONS - Market Value|Market Value repligen.com|RNA: Market Capitalization|Market Valuation CRSP (CRISPR Therapeutics)|Market Value GeneDx Holdings Corp.|Market Capitalization RARE (Ultragenyx Corp)|Market Value Beam Therapeutics (BEAM)|Sarepta Therapeutics, Inc. - Market Capitalization|Market Capitalization TWST (twistbioscience.com)|Market Value TXG (10x Genomics Corp)|Intellia Corp - Market Capitalization|Market Capitalization Stoke Therapeutics STOK|BLFS: Market Capitalization|WVE (Wave Life Sciences) - Market Value|Market Valuation MAZE|Market Value Sionna Therapeutics, Inc. SION|Market Value Prime Medicine Bio (PRME)|Market Capitalization Taysha|uniQure Pharma - Market Valuation|RGNX: Market Capitalization|SLDB: Market Valuation|OCGN (Ocugen Corp) - Market Capitalization|PACB: Market Capitalization|Market Valuation Benitec Biopharma Inc.|Market Valuation DSGN|Rocket Pharmaceuticals - Market Valuation|Market Capitalization FDMT|LXEO - Market Value|Korro Bio, Inc. - Market Valuation|EDIT: Market Capitalization|SLN - Market Value|PRQR - Market Capitalization|CDXS (Codexis, Inc.) - Market Valuation|Sangamo Therapeutics, Inc. - Market Value|Market Valuation NAUT|Market Valuation Metagenomi, Inc. (MGX)|Market Value precisionbiosciences.com (DTIL)|GBIO - Market Value|Market Capitalization BOLD (Boundless Bio Inc.)|Market Capitalization Exicure, Inc. XCUR|Imunon Inc - Market Capitalization|Market Capitalization phiopharma.com PHIO|Mustang Bio Corp (MBIO) - Market Value|Market Value TransCode Therapeutics (RNAZ)|BNGO (Bionano Genomics) - Market Capitalization|Market Valuation Applied DNA Sciences, Inc. (APDN)|Market Value Bluebird Bio (BLUE)|IPA - Market Value|Market Value omegatherapeutics.com OMGA|singulargenomics.com (OMIC) - Market Value|RGLS - Market Value|Market Capitalization Syros Pharmaceuticals Inc. SYRS|Telesis Bio, Inc. (TBIO) - Market Value|TCON - Market Capitalization|Market Value Unity Biotechnology, Inc.